These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17103336)

  • 41. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
    Smyth HD
    Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.
    Hindle M; Longest PW
    J Pharm Pharmacol; 2012 Sep; 64(9):1254-63. PubMed ID: 22881438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults.
    Eklund A; Tronde A; Johannes-Hellberg I; Gillen M; Borgström L
    Biopharm Drug Dispos; 2008 Oct; 29(7):382-95. PubMed ID: 18623040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces.
    Jones MD; Hooton JC; Dawson ML; Ferrie AR; Price R
    Pharm Res; 2008 Feb; 25(2):337-48. PubMed ID: 17952568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of actuator nozzle designs on the electrostatic charge generated in pressurised metered dose inhaler aerosols.
    Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
    Pharm Res; 2015 Apr; 32(4):1237-48. PubMed ID: 25270573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach.
    Sheth P; Sandell D; Conti DS; Holt JT; Hickey AJ; Saluja B
    AAPS J; 2017 Sep; 19(5):1396-1410. PubMed ID: 28593514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.
    D'Sa DJ; Lechuga-Ballesteros D; Chan HK
    Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
    Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
    Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
    Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler.
    Ganderton D; Lewis D; Davies R; Meakin B; Church T
    Respir Med; 2003 Nov; 97 Suppl D():S4-9. PubMed ID: 14753246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of physical and chemical stability in pressurised metered dose inhalers: potential new techniques.
    Ooi J; Traini D; Boyd BJ; Gaisford S; Young PM
    Expert Opin Drug Deliv; 2015; 12(10):1661-75. PubMed ID: 26067386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach.
    Hooton JC; Jones MD; Price R
    J Pharm Sci; 2006 Jun; 95(6):1288-97. PubMed ID: 16637052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.
    Zeng XM; Martin GP; Tee SK; Ghoush AA; Marriott C
    Int J Pharm; 1999 May; 182(2):133-44. PubMed ID: 10341303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
    Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An assessment of beclomethasone dipropionate clathrate formation in a model suspension metered dose inhaler.
    Bouhroum A; Burley JC; Champness NR; Toon RC; Jinks PA; Williams PM; Roberts CJ
    Int J Pharm; 2010 May; 391(1-2):98-106. PubMed ID: 20184946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonuniform Deposition of Pressurized Metered-Dose Aerosol in Spacer Devices.
    Ogrodnik N; Azzi V; Sprigge E; Fiset S; Matida E
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):490-500. PubMed ID: 27224033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma.
    Korenblat PE; Rosenwasser LJ
    Allergy Asthma Proc; 2010; 31(3):190-202. PubMed ID: 20482961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of force control agents in high-dose dry powder inhaler formulations.
    Begat P; Morton DA; Shur J; Kippax P; Staniforth JN; Price R
    J Pharm Sci; 2009 Aug; 98(8):2770-83. PubMed ID: 19067395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.